Solaris Endovascular Reports Positive 12-Month Results from the Solaris SX™ Iliac Multicenter Study
European real-world data show strong Solaris SX™ performance in PAD, complementing findings from the DEScover sirolimus-eluting program NEW YORK, NY, UNITED STATES, November 21, 2025 /EINPresswire.com/ -- Solaris Endovascular today announced …